OPA1 and myocardial infarction: Whether this modest expression of the long form of OPA1 (∼10% in OPA1tg hearts versus ∼0.6% of total OPA1 in WT) is able to reduce infarct size in an in vivo model of myocardial infarction remains to be investigated.